Loading...
XNAS
PTHL
Market cap4mUSD
Aug 28, Last price  
0.32USD
Name

Pheton Holdings Ltd

Chart & performance

D1W1MN
XNAS:PTHL chart
P/E
P/S
10.07
EPS
Div yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Pheton Holdings Ltd is a specialized healthcare enterprise focused on the development and commercialization of software and devices integral to brachytherapy treatments. At the core of its offerings is a proprietary treatment planning system, a sophisticated form of radiation therapy. This system facilitates the internal placement of radioactive sources within cancer patients, a process designed to eradicate malignant cells and reduce tumor size. Specifically named FTTPS, this advanced planning tool is engineered for the treatment of diverse malignant tumors. It meticulously determines the precise target volume, calculates the optimal prescription dose, establishes critical dose limitations to safeguard at-risk organs, and ultimately generates a comprehensive dose distribution plan for brachytherapy in oncology patients. Established in 1998, the company maintains its headquarters in Beijing, China. Pheton Holdings Ltd operates as a subsidiary under the ownership of ZJW (BVI) LTD.
IPO date
Sep 05, 2024
Employees
Domiciled in
CN
Incorporated in
KY

Valuation

No data to show